Citi Upgrades MacroGenics (MGNX) to Buy, 'Expanding ADC Pipeline Provides Good Set-Up for Shares in 2024'
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz upgraded MacroGenics (NASDAQ: MGNX) from Neutral to Buy with a price target of $13.00 (from $7.00).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
